Browse by author
Lookup NU author(s): Dr Nahoum Anthony, Charlotte Jennings, Dr Mathew Martin, Dr Richard NobleORCiD, Nicole Phillips, Huw ThomasORCiD, Professor Martin NobleORCiD, Professor Steve Wedge, Dr Hannah Stewart, Professor Mike Waring
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
A major drawback of cytotoxic chemotherapy is the lack of selectivity toward noncancerous cells. The targeted delivery of cytotoxic drugs to tumor cells is a longstanding goal in cancer research. We proposed that covalent inhibitors could be adapted to deliver cytotoxic agents, conjugated to the β-position of the Michael acceptor, via an addition–elimination mechanism promoted by covalent binding. Studies on model systems showed that conjugated 5-fluorouracil (5FU) could be released upon thiol addition in relevant time scales. A series of covalent epidermal growth factor receptor (EGFR) inhibitors were synthesized as their 5FU derivatives. Achieving the desired release of 5FU was demonstrated to depend on the electronics and geometry of the compounds. Mass spectrometry and NMR studies demonstrated an anilinoquinazoline acrylate ester conjugate bound to EGFR with the release of 5FU. This work establishes that acrylates can be used to release conjugated molecules upon covalent binding to proteins and could be used to develop targeted therapeutics.
Author(s): Morese PA, Anthony N, Bodnarchuk M, Jennings C, Martin MP, Noble RA, Phillips N, Thomas HD, Wang LZ, Lister A, Noble MEM, Ward RA, Wedge SR, Stewart HL, Waring MJ
Publication type: Article
Publication status: Published
Journal: Journal of Medicinal Chemistry
Year: 2023
Volume: 66
Issue: 17
Pages: 12324-12341
Online publication date: 30/08/2023
Acceptance date: 30/08/2023
Date deposited: 18/09/2023
ISSN (print): 0022-2623
ISSN (electronic): 1520-4804
Publisher: American Chemical Society
URL: https://doi.org/10.1021/acs.jmedchem.3c00845
DOI: 10.1021/acs.jmedchem.3c00845
Altmetrics provided by Altmetric
